Torsemide Tablet
NDC 50090-7425
Product Information
Torsemide is a ANDA-approved product labeled by A-s Medication Solutions. Torsemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 50090-7425 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
60;H
Code Structure Chart
Product Details
What is NDC 50090-7425?
What are the uses of this product?
What are Active Ingredients of this product?
- TORSEMIDE 100 mg/1 - A pyridine and sulfonamide derivative that acts as a sodium-potassium chloride symporter inhibitor (loop diuretic). It is used for the treatment of EDEMA associated with CONGESTIVE HEART FAILURE; CHRONIC RENAL INSUFFICIENCY; and LIVER DISEASES. It is also used for the management of HYPERTENSION.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TORSEMIDE (UNII: W31X2H97FB)
- TORSEMIDE (UNII: W31X2H97FB) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK)
- PVP (UNII: FZ989GH94E)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 198370 - torsemide 100 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.